Taiko Pharmaceutical Co. Ltd. | |
Stock Exchange | Tokyo Stock Exchange |
EPS |
JPY98.77 |
Market Cap |
JPY31.86 B |
Shares Outstanding |
14.34 M |
Public Float |
8.46 M |
Address |
ORIX Honmachi Building, 16F Osaka Osaka 550 Japan |
Employees | - |
Website | http://www.seirogan.co.jp |
Updated | 07/08/2019 |
Taiko Pharmaceutical Co., Ltd. engages in the manufacture and sale of general medications particularly non-prescription gastrointestinal drugs and designated quasi drugs, and sanitation control products. It operates through the following segments: Pharmaceuticals, Infection Control, and Others. The Pharmaceuticals segment handles the manufacture, procurement and sale of non-prescription (OTC) drugs in Japan and overseas. |